Avicena, an Australian medical technology company, develops advanced biosecurity solutions to protect communities and economies from significant human and animal disease outbreaks. Their Sentinel platform is the next generation of pathogen detection technology, offering automated, accurate, and scalable diagnostic screening. Utilizing LAMP technology, a highly sensitive method similar to PCR, Sentinel can quickly adapt to existing tests for a wide variety of human and animal pathogens.
